Replies to post #1279 on Enanta Pharmaceuticals Inc (ENTA)

[NY1972]

4 million shares shorted @ 12/31/2015. SS expects Merck to take ABBV's market share in 2016. Luly expects increasing earnings due to:

2D (2-DAA) regimen marketed in Japan without RBV

Viekira QD: Regulatory decision 3Q16

Viekira: RBV-free in GT1b cirrhotic patients


Will 1/28 be the drop dead date for the SS?